Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Etronex Gel
- Development stage
- Unknown
- Lead developer
- MetaneX Life Science
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Etronex Gel is a branded generic topical pain relief formulation marketed by MetaneX Life Science. It is designed to alleviate localized pain, swelling, and inflammation associated with musculoskeletal disorders, joint pain, sprains, strains, and arthritic conditions. The gel formulation typically combines the selective cyclooxygenase-2 (COX-2) inhibitor etoricoxib with counterirritants such as methyl salicylate and menthol, alongside linseed oil to enhance dermal absorption and provide additional anti-inflammatory benefits. Applied topically, it delivers rapid local relief with minimal systemic side effects.
- Brand names
- Etronex Gel
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)
Beyond the preview
Go deeper on Etronex Gel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Etronex Gel.